Agree Eire, "The big news this year will be FDA approval of the EFS trial with our TAVR, potential Breakthrough status and news of first successful patients off the hospital bed with DurAVR THV inside."
I know we are all hoping the Mercer cash will get us over the line here within the next 12 mths.
I see we'll possibly get back to 7.50 at this rate
I have also seen with other co's CEO's ride the SP into new lows then take massive options negating the need to buy on market and naturally ride the uptrend creating even more wealth then their over paid salaries. Anyhow, i suppose once we get first successful human trails, FDA approvals, partner deals and are cash flow positive WP will say i told you so..
Until then it still stinks of manipulation to me so unless the SP goes back under 5 i'll wait b4 deploying more capital
Ann: Expanded Funding Package, page-28
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.20 |
Change
-0.550(5.12%) |
Mkt cap ! $215.6M | |||
| Open | High | Low | Value | Volume |
| $10.73 | $10.73 | $10.15 | $109.7K | 10.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 490 | $10.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.20 | 911 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |